An examination of some complexing agents for ability to remove intracellularly deposited plutonium.
D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D002019:Bufexamac / Q000378:metabolism; D002614:Chelating Agents / Q000378:metabolism*; D002867:Chromones / Q000378:metabolism; D006224:Cricetinae; D003676:Deferoxamine / Q000031:analogs & derivatives / Q000378:metabolism; D005260:Female; D005998:Glycine / Q000031:analogs & derivatives / Q000378:metabolism; D006877:Hydroxamic Acids / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008647:Mesocricetus; D004369:Pentetic Acid / Q000378:metabolism; D010879:Piperazines / Q000378:metabolism; D011005:Plutonium / Q000378:metabolism*; D011725:Pyridines / Q000378:metabolism
D002614:Chelating Agents; D002867:Chromones; D006877:Hydroxamic Acids; D010879:Piperazines; D011725:Pyridines; C024588:2,6-pyridinedicarbohydroxamic acid; C024590:2,3-dihydroxybenzoyl-N-glycine; C007049:chromone-2-carbohydroxamic acid; D002019:Bufexamac; D011005:Plutonium; C003305:rhodotorulic acid; C024589:N-stearoyldesferrioxamine; D004369:Pentetic Acid; D003676:Deferoxamine; D005998:Glycine